scispace - formally typeset
S

Sandra B. Brennan

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  23
Citations -  816

Sandra B. Brennan is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer & Biopsy. The author has an hindex of 12, co-authored 21 publications receiving 685 citations. Previous affiliations of Sandra B. Brennan include Mater Misericordiae Hospital & Cornell University.

Papers
More filters
Journal ArticleDOI

Breast MRI Screening of Women With a Personal History of Breast Cancer

TL;DR: It was found that breast MRI screening of women with only a personal history of breast cancer was clinically valuable finding malignancies in 12%, with a reasonable biopsy rate (PPV, 39%).
Journal ArticleDOI

Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.

TL;DR: Mild, moderate, and marked background parenchymal enhancement is associated with a significantly lower rate of BI-RADS categories 1 and 2 assessments and a significantly higher rate ofBI-R ADS category 3 assessments than minimal enhancement.
Journal ArticleDOI

Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.

TL;DR: This study assessed the rate of upgrade to carcinoma at surgical excision (EXC) and confirmed that mammary intraductal papilloma without atypia identified at core‐needle biopsy (CNB) is controversial.
Journal ArticleDOI

Levator ani injury in primiparous women with forceps delivery for fetal distress, forceps for second stage arrest, and spontaneous delivery

TL;DR: To compare levator ani muscle injury rates in primiparous women who had a forceps delivery owing to fetal distress with women delivered by forceps for second stage arrest, a historical control group of women who delivered spontaneously are compared.
Journal ArticleDOI

MR imaging features of triple-negative breast cancers.

TL;DR: To compare the magnetic resonance imaging features of TN breast cancers with estrogen (ER) and progesterone (PR) positive, human epidermal growth factor receptor (HER2) negative cancers, retrospective review identified 140 patients with TN breast cancer who underwent a preoperative breast MRI between 2003 and 2008.